{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:22:00Z","timestamp":1784290920739,"version":"3.55.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370672"],"award-info":[{"award-number":["81370672"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Science & Technology Commission","award":["Z131107002213050"],"award-info":[{"award-number":["Z131107002213050"]}]},{"name":"Peking Union Medical College New Star","award":["2011"],"award-info":[{"award-number":["2011"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.blre.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T20:32:38Z","timestamp":1489005158000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?"],"prefix":"10.1016","volume":"31","author":[{"given":"Chunlan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-2144","authenticated-orcid":false,"given":"Xufei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjh.13156","article-title":"Guidelines on the diagnosis and investigation of AL amyloidosis","volume":"168","author":"Gillmore","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0010","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"issue":"13","key":"10.1016\/j.blre.2017.03.002_bb0015","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0020","first-page":"290","article-title":"In vitro AL-amyloid formation by rat and human mesangial cells","volume":"74","author":"Tagouri","year":"1996","journal-title":"Lab Invest"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0025","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood.V91.8.2948.2948_2948_2954","article-title":"Evidence that amyloidogenic light chains undergo antigen-driven selection","volume":"91","author":"Perfetti","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cyto.b.20512","article-title":"Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders","volume":"78","author":"Paiva","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"13","key":"10.1016\/j.blre.2017.03.002_bb0035","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood-2010-12-324665","article-title":"The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis","volume":"117","author":"Paiva","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2017.03.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-10-673095","article-title":"Phenotypic, transcriptomic and genomic features of clonal plasma cells in light chain amyloidosis","author":"Paiva","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.blre.2017.03.002_bb0045","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2007-11-122101","article-title":"Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability","volume":"111","author":"Bochtler","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2017.03.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.34","article-title":"Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death","volume":"5","author":"Warsame","year":"2015","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/13506129.2013.854766","article-title":"Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan\/dexamethasone","volume":"21","author":"Bochtler","year":"2014","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0060","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood-2004-04-1424","article-title":"Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis","volume":"105","author":"Abraham","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clml.2011.09.217","article-title":"Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis","volume":"12","author":"Zhou","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.blre.2017.03.002_bb0070","article-title":"Exome sequencing to define a genetic signature of plasma cells in systemic AL amyloidosis","volume":"122","author":"Rowczienio","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/13506129.2011.588977","article-title":"Dysregulation of miRNAs in AL amyloidosis","volume":"18","author":"Weng","year":"2011","journal-title":"Amyloid"},{"issue":"24","key":"10.1016\/j.blre.2017.03.002_bb0080","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jcp.2009.065474","article-title":"Immunophenotype of neoplastic plasma cells in AL amyloidosis","volume":"62","author":"Deshmukh","year":"2009","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.blre.2017.03.002_bb0090","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2008-03-143040","article-title":"Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2","volume":"112","author":"Arendt","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2017.03.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-11-681650","article-title":"Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis","author":"Weiss","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/clin.1994.1070","article-title":"Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenstrom's macroglobulinemia","volume":"71","author":"Ozaki","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0105","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2002-01-0114","article-title":"Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment","volume":"100","author":"Perfetti","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0110","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2002-09-2707","article-title":"Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL)","volume":"101","author":"Abraham","year":"2003","journal-title":"Blood"},{"issue":"34","key":"10.1016\/j.blre.2017.03.002_bb0115","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1021\/bi00034a001","article-title":"A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains","volume":"34","author":"Stevens","year":"1995","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/13506120009146835","article-title":"Four structural risk factors identify most fibril-forming kappa light chains","volume":"7","author":"Stevens","year":"2000","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005169","article-title":"Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis","volume":"4","author":"Poshusta","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.blre.2017.03.002_bb0130","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1073\/pnas.91.12.5446","article-title":"A role for destabilizing amino acid replacements in light-chain amyloidosis","volume":"91","author":"Hurle","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"49","key":"10.1016\/j.blre.2017.03.002_bb0140","doi-asserted-by":"crossref","first-page":"14259","DOI":"10.1021\/bi7013773","article-title":"Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains","volume":"46","author":"Connors","year":"2007","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abio.2001.5187","article-title":"Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption\/ionization mass spectrometry","volume":"295","author":"Lim","year":"2001","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbadis.2010.07.022","article-title":"Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains","volume":"1812","author":"Davern","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0155","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1110\/ps.8.10.1982","article-title":"Local water bridges and protein conformational stability","volume":"8","author":"Petukhov","year":"1999","journal-title":"Protein Sci"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0160","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.168.3.1099","article-title":"Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen","volume":"168","author":"Wallick","year":"1988","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-9120(84)90360-6","article-title":"Glycoproteins: their structure, biosynthesis and possible clinical implications","volume":"17","author":"Schachter","year":"1984","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0170","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI112643","article-title":"Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture","volume":"78","author":"Buxbaum","year":"1986","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/path.2607","article-title":"Fibril protein fragmentation pattern in systemic AL-amyloidosis","volume":"219","author":"Enqvist","year":"2009","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0180","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1365-2141.1999.01778.x","article-title":"pH-dependent fibrillogenesis of a VkappaIII Bence Jones protein","volume":"107","author":"Rostagno","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2017.03.002_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-3083.1998.00352.x","article-title":"Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein","volume":"48","author":"Engvig","year":"1998","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0190","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1074\/mcp.M700545-MCP200","article-title":"Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue","volume":"7","author":"Lavatelli","year":"2008","journal-title":"Mol Cell Proteomics"},{"issue":"24","key":"10.1016\/j.blre.2017.03.002_bb0195","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"issue":"45","key":"10.1016\/j.blre.2017.03.002_bb0200","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1021\/bi101351c","article-title":"The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain","volume":"49","author":"Klimtchuk","year":"2010","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13506120309041728","article-title":"Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit","volume":"10","author":"Ancsin","year":"2003","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0215","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/ki.1997.484","article-title":"Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils","volume":"52","author":"Inoue","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.blre.2017.03.002_bb0220","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-0173(98)00055-1","article-title":"Basement membrane, microfibrils and beta amyloid fibrillogenesis in Alzheimer's disease: high resolution ultrastructural findings","volume":"29","author":"Inoue","year":"1999","journal-title":"Brain Res Rev"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0225","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2017.03.002_bb0230","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposi- tion in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease","volume":"90","author":"Schmechel DE","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0235","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0245","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","article-title":"Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis","volume":"92","author":"Tennent","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0250","first-page":"911","article-title":"Amyloid a protein amyloidosis induced in apolipoprotein-E-deficient mice","volume":"151","author":"Hoshii","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2017.03.002_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/clin.1997.4397","article-title":"Apolipoprotein E and apolipoprotein A1 knock-out mice readily develop amy- loid a protein amyloidosis","volume":"85","author":"E-BRaC","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"10.1016\/j.blre.2017.03.002_bb0260","first-page":"525","article-title":"Serum amyloid P component enhances induction of murine amyloidosis","volume":"77","author":"Togashi","year":"1997","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0265","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/JVI.68.4.2135-2141.1994","article-title":"Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo red [corrected]","volume":"68","author":"Caughey","year":"1994","journal-title":"J Virol"},{"issue":"43","key":"10.1016\/j.blre.2017.03.002_bb0270","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1021\/bi970408h","article-title":"Interaction between glycosaminoglycans and immunoglobulin light chains","volume":"36","author":"Jiang","year":"1997","journal-title":"Biochemistry"},{"issue":"20","key":"10.1016\/j.blre.2017.03.002_bb0275","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.1074\/jbc.M008423200","article-title":"Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"issue":"50","key":"10.1016\/j.blre.2017.03.002_bb0280","doi-asserted-by":"crossref","first-page":"31617","DOI":"10.1074\/jbc.272.50.31617","article-title":"Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red","volume":"272","author":"Watson","year":"1997","journal-title":"J Biol Chem"},{"issue":"52","key":"10.1016\/j.blre.2017.03.002_bb0285","doi-asserted-by":"crossref","first-page":"33118","DOI":"10.1074\/jbc.272.52.33118","article-title":"Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation","volume":"272","author":"Hasegawa","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0290","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1432-1327.1999.00957.x","article-title":"Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth","volume":"266","author":"McLaurin","year":"1999","journal-title":"Eur J Biochem"},{"issue":"48","key":"10.1016\/j.blre.2017.03.002_bb0295","doi-asserted-by":"crossref","first-page":"37672","DOI":"10.1074\/jbc.M110.149575","article-title":"Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils","volume":"285","author":"Ren","year":"2010","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0300","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1074\/jbc.M114.615401","article-title":"Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans","volume":"290","author":"Blancas-Mejia","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpc.2011.05.011","article-title":"Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction","volume":"158","author":"Martin","year":"2011","journal-title":"Biophys Chem"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0310","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1523-1755.2005.00571.x","article-title":"Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage","volume":"68","author":"Keeling","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0315","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000071288","article-title":"Insights into mechanisms responsible for mesangial alterations associated with fibrogenic glomerulopathic light chains","volume":"94","author":"Teng","year":"2003","journal-title":"Nephron Physiol"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0325","first-page":"375","article-title":"Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta","volume":"147","author":"Zhu","year":"1995","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0330","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCHEARTFAILURE.108.788687","article-title":"Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition","volume":"1","author":"Biolo","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.blre.2017.03.002_bb0335","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-biochem-072711-163904","article-title":"Extracellular chaperones and proteostasis","volume":"82","author":"Wyatt","year":"2013","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0340","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1471-4159.2001.00419.x","article-title":"Role of alpha2-macroglobulin in regulating amyloid beta-protein neurotoxicity: protective or detrimental factor?","volume":"78","author":"Fabrizi","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.blre.2017.03.002_bb0345","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1134\/S1819712407010060","article-title":"Serum macroglobulin induces prion protein transition","volume":"1","author":"Adler","year":"2007","journal-title":"Neurochem J"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0350","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1096\/fj.06-7986com","article-title":"The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures","volume":"21","author":"Yerbury","year":"2007","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/13506129909007335","article-title":"Casein related amyloid, characterization of a new and unique amyloid protein isolated from bovine corpora amylacea","volume":"6","author":"Niewold","year":"1999","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0360","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1073\/pnas.95.6.3275","article-title":"Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation","volume":"95","author":"Hughes","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0365","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1006\/bbrc.1994.2580","article-title":"Purification and characterization of brain clusterin","volume":"204","author":"Oda","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0370","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/bbrc.1999.0781","article-title":"Clusterin prevents aggregation of neuropeptide 106-126 in vitro","volume":"259","author":"McHattie","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.blre.2017.03.002_bb0375","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1046\/j.1432-1033.2002.02957.x","article-title":"Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin","volume":"269","author":"Hatters","year":"2002","journal-title":"Eur J Biochem"},{"issue":"44","key":"10.1016\/j.blre.2017.03.002_bb0380","doi-asserted-by":"crossref","first-page":"26041","DOI":"10.1074\/jbc.270.44.26041","article-title":"Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component","volume":"270","author":"Janciauskiene","year":"1995","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.blre.2017.03.002_bb0385","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1046\/j.1471-4159.1997.69051904.x","article-title":"Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein","volume":"69","author":"Narita","year":"1997","journal-title":"J Neurochem"},{"issue":"30","key":"10.1016\/j.blre.2017.03.002_bb0390","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1074\/jbc.272.30.18644","article-title":"Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2\/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide","volume":"272","author":"Hammad","year":"1997","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.blre.2017.03.002_bb0395","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1007\/s00018-011-0684-8","article-title":"Clusterin facilitates in vivo clearance of extracellular misfolded proteins","volume":"68","author":"Wyatt","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.blre.2017.03.002_bb0400","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/bj3160671","article-title":"Apolipoprotein J and Alzheimer's amyloid beta solubility","volume":"316","author":"Matsubara","year":"1996","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0405","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/bbrc.1996.6019","article-title":"Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation","volume":"231","author":"Gouin-Charnet","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0410","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(00)01530-1","article-title":"Molecular chaperone properties of serum amyloid P component","volume":"473","author":"Coker","year":"2000","journal-title":"FEBS Lett"},{"issue":"89","key":"10.1016\/j.blre.2017.03.002_bb0415","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.blre.2017.03.002_bb0420","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.blre.2017.03.002_bb0425","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molmed.2011.01.005","article-title":"Disease-associated amyloid and misfolded protein aggregates activate the inflammasome","volume":"17","author":"Masters","year":"2011","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0430","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-009-0096-5","article-title":"Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages","volume":"59","author":"Jozefowski","year":"2010","journal-title":"Inflamm Res"},{"issue":"11","key":"10.1016\/j.blre.2017.03.002_bb0435","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1523\/JNEUROSCI.20-11-03937.2000","article-title":"The plasmin system is induced by and degrades amyloid-beta aggregates","volume":"20","author":"Tucker","year":"2000","journal-title":"J Neurosci"},{"issue":"25","key":"10.1016\/j.blre.2017.03.002_bb0440","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"10.1016\/j.blre.2017.03.002_bb0445","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","article-title":"The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration","volume":"23","author":"Melchor","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0450","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1385\/JMN:20:3:287","article-title":"The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer's disease","volume":"20","author":"Melchor","year":"2003","journal-title":"J Mol Neurosci"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0455","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1538-7836.2007.02457.x","article-title":"Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses","volume":"5","author":"Bouma","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.blre.2017.03.002_bb0460","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.emboj.7600650","article-title":"Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1\/2 activation","volume":"24","author":"Medina","year":"2005","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0465","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.mcn.2004.11.001","article-title":"Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation","volume":"28","author":"Kranenburg","year":"2005","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0470","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.1999.01591.x","article-title":"Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation","volume":"106","author":"Comenzo","year":"1999","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0475","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V98.3.714","article-title":"The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden","volume":"98","author":"Comenzo","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0480","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2011-05-355784","article-title":"The repertoire of lambda light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44","volume":"119","author":"Perfetti","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2017.03.002_bb0485","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1002\/art.22959","article-title":"Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival","volume":"56","author":"Prokaeva","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbapap.2005.08.014","article-title":"Clinical aspects of systemic amyloid diseases","volume":"1753","author":"Obici","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.blre.2017.03.002_bb0495","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0500","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0505","first-page":"611","article-title":"Amyloidosis and cardiac involvement","volume":"151","author":"Cacoub","year":"2000","journal-title":"Ann Med Interne (Paris)"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0510","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0025-6196(12)61493-1","article-title":"Clinical significance of histopathologic patterns of cardiac amyloidosis","volume":"59","author":"Smith","year":"1984","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0515","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0002-9149(70)90736-8","article-title":"Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients","volume":"26","author":"Buja","year":"1970","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0520","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.carpath.2007.05.008","article-title":"Histomorphometric analysis of intramyocardial vessels in primary and senile amyloidosis: epicardium versus endocardium","volume":"17","author":"Sharma","year":"2008","journal-title":"Cardiovasc Pathol"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0525","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00005792-198111000-00004","article-title":"Clinical-pathologic differentiation of common amyloid syndromes","volume":"60","author":"Wright","year":"1981","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0530","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-8703(95)90362-3","article-title":"Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients","volume":"130","author":"Arbustini","year":"1995","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0535","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2005-11-4385","article-title":"Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL","volume":"107","author":"Palladini","year":"2006","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.blre.2017.03.002_bb0540","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","article-title":"Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts","volume":"104","author":"Liao","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0545","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9440(10)62244-4","article-title":"Cellular response of cardiac fibroblasts to amyloidogenic light chains","volume":"166","author":"Trinkaus-Randall","year":"2005","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.blre.2017.03.002_bb0550","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1096\/fj.15-272179","article-title":"Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis","volume":"29","author":"Lavatelli","year":"2015","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0555","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2353\/ajpath.2006.060183","article-title":"Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts","volume":"169","author":"Monis","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2017.03.002_bb0560","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/srep01278","article-title":"Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes","volume":"3","author":"Levinson","year":"2013","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.blre.2017.03.002_bb0565","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.15252\/emmm.201404190","article-title":"Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity","volume":"6","author":"Guan","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0570","first-page":"107","article-title":"Formation of \u201camyloid\u201d fibrils in vitro by action of human kidney lysosomal enzymes on Bence Jones proteins","volume":"84","author":"Epstein","year":"1974","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0575","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0019-2791(72)90278-9","article-title":"Polymer formation during the degradation of human light chain and Bence-Jones proteins by an extrct of the lysosomal fraction of normal human kidney","volume":"9","author":"Tan","year":"1972","journal-title":"Immunochemistry"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0580","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.blre.2017.03.002_bb0585","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.blre.2017.03.002_bb0590","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00395-013-0378-5","article-title":"Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity","volume":"108","author":"Guan","year":"2013","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"10.1016\/j.blre.2017.03.002_bb0595","doi-asserted-by":"crossref","first-page":"H2305","DOI":"10.1152\/ajpheart.00503.2011","article-title":"Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins","volume":"301","author":"Migrino","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.blre.2017.03.002_bb0600","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-02-702696","article-title":"Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis","author":"Kastritis","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0605","doi-asserted-by":"crossref","first-page":"H95","DOI":"10.1152\/ajpheart.00186.2013","article-title":"Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish","volume":"305","author":"Mishra","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0610","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/13506129.2012.733741","article-title":"Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report","volume":"19","author":"Shin","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.blre.2017.03.002_bb0625","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-10-525634","article-title":"A Caenorhabditis elegans\u2013based assay recognizes immunoglobulin light chains causing heart amyloidosis","author":"Diomede","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0630","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAP.0000000000000056","article-title":"Renal involvement in monoclonal gammopathy","volume":"22","author":"Al-Hussain","year":"2015","journal-title":"Adv Anat Pathol"},{"issue":"7","key":"10.1016\/j.blre.2017.03.002_bb0635","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1440-1827.2007.02116.x","article-title":"Role of translational research advancing the understanding of the pathogenesis of light chain-mediated glomerulopathies","volume":"57","author":"Teng","year":"2007","journal-title":"Pathol Int"},{"key":"10.1016\/j.blre.2017.03.002_bb0640","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000096764","article-title":"The mesangium as a target for glomerulopathic light and heavy chains: pathogenic considerations in light and heavy chain-mediated glomerular damage","volume":"153","author":"Keeling","year":"2007","journal-title":"Contrib Nephrol"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0645","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/labinvest.3700069","article-title":"Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns","volume":"84","author":"Teng","year":"2004","journal-title":"Lab Invest"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0650","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/labinvest.3700161","article-title":"AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells","volume":"84","author":"Keeling","year":"2004","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0655","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/01913123.2013.861568","article-title":"Extrusion of amyloid fibrils to the extracellular space in experimental mesangial AL-amyloidosis: transmission and scanning electron microscopy studies and correlation with renal biopsy observations","volume":"38","author":"Teng","year":"2014","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0660","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ki.2014.122","article-title":"An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes","volume":"86","author":"Teng","year":"2014","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.blre.2017.03.002_bb0665","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0670","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1182\/blood-2007-07-099481","article-title":"Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation","volume":"110","author":"Sanchorawala","year":"2007","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.blre.2017.03.002_bb0675","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1002\/cncr.27660","article-title":"Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis","volume":"118","author":"Cordes","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.blre.2017.03.002_bb0680","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/CCO.0b013e32801494c6","article-title":"Transplantation for amyloidosis","volume":"19","author":"Gertz","year":"2007","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"10.1016\/j.blre.2017.03.002_bb0685","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbmt.2015.10.010","article-title":"Evolution of hematopoietic cell transplantation for immunoglobulin light chain amyloidosis","volume":"22","author":"Sher","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.blre.2017.03.002_bb0690","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajh.24433","article-title":"Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment","volume":"91","author":"Gertz","year":"2016","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.blre.2017.03.002_bb0695","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2003-08-2788","article-title":"Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation","volume":"103","author":"Palladini","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2017.03.002_bb0700","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.2008.07327.x","article-title":"Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone","volume":"143","author":"Lebovic","year":"2008","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0705","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1182\/blood-2009-11-253237","article-title":"Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement","volume":"116","author":"Dietrich","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0710","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3324\/haematol.2013.095463","article-title":"Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach","volume":"99","author":"Palladini","year":"2014","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.blre.2017.03.002_bb0715","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1200\/JCO.2015.63.6530","article-title":"First-in-human phase I\/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction","volume":"34","author":"Gertz","year":"2016","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.blre.2017.03.002_bb0720","article-title":"Results of phase I study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis [abstract]","volume":"126","author":"Arielle","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2017.03.002_bb0725","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","article-title":"Therapeutic clearance of amyloid by antibodies to serum amyloid P component","volume":"373","author":"Richards","year":"2015","journal-title":"N Engl J Med"},{"issue":"7320","key":"10.1016\/j.blre.2017.03.002_bb0730","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature09494","article-title":"Antibodies to human serum amyloid P component eliminate visceral amyloid deposits","volume":"468","author":"Bodin","year":"2010","journal-title":"Nature"},{"issue":"6886","key":"10.1016\/j.blre.2017.03.002_bb0735","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.blre.2017.03.002_bb0740","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","article-title":"Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide","volume":"31","author":"Gobbi","year":"2010","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.blre.2017.03.002_bb0745","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jmb.2008.06.062","article-title":"The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA","volume":"381","author":"Meng","year":"2008","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.blre.2017.03.002_bb0750","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/08982104.2013.838258","article-title":"Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury","volume":"24","author":"Truran","year":"2014","journal-title":"J Liposome Res"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T21:59:28Z","timestamp":1719093568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X16300431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0268960X16300431"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2017.03.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}